These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34416878)

  • 1. Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome.
    Yu Y; Tan P; Zhuang Z; Wang Z; Zhu L; Qiu R; Xu H
    BMC Med Genomics; 2021 Aug; 14(1):206. PubMed ID: 34416878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment.
    Zhao T; Xiao X; Li L; Zhu J; He W; Zhang Q; Wu J; Wu X; Yuan T
    Front Endocrinol (Lausanne); 2024; 15():1354214. PubMed ID: 38948525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum metabolomics of Indian women with polycystic ovary syndrome using
    RoyChoudhury S; Mishra BP; Khan T; Chattopadhayay R; Lodh I; Datta Ray C; Bose G; Sarkar HS; Srivastava S; Joshi MV; Chakravarty B; Chaudhury K
    Mol Biosyst; 2016 Oct; 12(11):3407-3416. PubMed ID: 27714060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
    Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
    Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight.
    Diboun I; Ramanjaneya M; Ahmed L; Bashir M; Butler AE; Albagha O; Abou-Samra AB; Atkin SL; Mazloum NA; Elrayess MA
    Front Endocrinol (Lausanne); 2021; 12():638727. PubMed ID: 34211435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.
    Zhang Z; Hong Y; Chen M; Tan N; Liu S; Nie X; Zhou W
    Metabolomics; 2020 Jan; 16(2):20. PubMed ID: 31980950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.
    Yang Z; Cai X; Xu X; Xu Z; Ye S; Wang Y; Hong Y; Shen B; Liao Q; Xie Z; Wang X
    Anal Biochem; 2022 Jun; 647():114665. PubMed ID: 35339450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics.
    Zhao X; Feng X; Zhao X; Jiang Y; Li X; Niu J; Meng X; Wu J; Xu G; Hou L; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():659268. PubMed ID: 34149613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted metabolomics analysis of serum and follicular fluid samples from women with polycystic ovary syndrome.
    Xu WL; Liu GY; Zhang N; Ren J; Li XY; Li YQ; Chen Y; Liu JY
    Minerva Endocrinol (Torino); 2023 Jun; 48(2):160-171. PubMed ID: 33103870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry.
    Jia C; Xu H; Xu Y; Xu Y; Shi Q
    Mol Reprod Dev; 2019 Mar; 86(3):292-297. PubMed ID: 30624822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
    Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
    J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
    Hou E; Zhao Y; Hang J; Qiao J
    Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure.
    Chen J; Zhou Q; Zhang Y; Tan W; Gao H; Zhou L; Xiao S; Gao J; Li J; Zhu Z
    Bioengineered; 2021 Dec; 12(1):8778-8792. PubMed ID: 34696698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients.
    Sun L; Hu W; Liu Q; Hao Q; Sun B; Zhang Q; Mao S; Qiao J; Yan X
    J Proteome Res; 2012 May; 11(5):2937-46. PubMed ID: 22428626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
    Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
    J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
    Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
    Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.